Inca00186 drug page Clinical trials

Trials with Inca00186

Every colorectal cancer trial that includes this drug. Those looking for patients come first.

1Trials
0Recruiting
6Countries
57Planned patients

Showing 1–1 of 1

Study of INCA 0186 in Subjects With Advanced Solid Tumors
Finished Phase 1 57 patients NCT04989387

This is an open-label, nonrandomized, multicenter, dose escalation, and dose expansion first-in human (FIH) Phase 1 study to determine the safety, tolerability, PK, pharmacodynamics, and preliminary efficacy of INCA00186 when given alone o…

United States, Austria, Belgium, Netherlands and 2 more Oct 2021 – Sept 2024 Interventional
Combined with: INCB106385Retifanlimab